KVUE logo

KENVUE INC

KVUENYSE
πŸ† #308 by market capEarnings Nov 2 Β· PreUS Equity
$19.05β–² $0.02 (+0.11%)
πŸŒ™ After hours$19.10β–² 0.28%Regular close Β· extended-hours price shown
1hβ€”
24hβ–² 0.1%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$36.58B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+1.8%
Slowing
πŸ“ŠGross Margin
58.6%
Healthy
πŸ’΅FCF Margin
12.4%
Healthy
βš–οΈP/S Ratio
2.4x
Cheap
Otter Score
55
Weak
No chart data available for KVUE.

Trading Snapshot

Day Range
$18.86 – $19.30
52-Week Range
$14.02 – $21.96
Volume
$4.34B
Avg Volume
$3.40B
Shares Outstanding
1.92B
Next Earnings
Oct 27, 2026

Fundamentals Snapshot

Annual Revenue
$15.12B
Last Q Revenue
$3.96B
P/E Ratio
22.0
P/S Ratio
2.4x
EPS (TTM)
$0.86
Dividend Yield
4.36%

Why Investors Own KVUE

  • βœ“High-growth profile β€” revenue up +22.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$15.12Bβ–² +19.6% YoY
Gross Margin (TTM)
58.2%β–² +4.5% YoY
Operating Income (TTM)
$3.90Bβ–² +19.6% YoY
Free Cash Flow (TTM)
$923Mβ–² +19.6% YoY

About KENVUE INC

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
55/100

Analyst Price Target

β“˜
Average Target
$24.10
β–² +26.5% Upside
High Target$27.91
Low Target$19.75
Based on 21 analysts

Latest News & Updates